Literature DB >> 30446289

Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms.

Alessandro Matarese1, Celestino Sardu2, Jun Shu3, Gaetano Santulli4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30446289      PMCID： PMC6324983          DOI： 10.1016/j.ijcard.2018.10.075

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

1.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

2.  Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).

Authors:  Harjit Chahal; Susan R Heckbert; R Graham Barr; David A Bluemke; Aditya Jain; Mohammadali Habibi; Alvaro Alonso; Richard Kronmal; David R Jacobs; Joao A C Lima; Karol E Watson; Kiang Liu; Lewis J Smith; Philip Greenland
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

3.  Chronic obstructive pulmonary disease and the development of atrial fibrillation.

Authors:  Maxim Grymonprez; Vincent Vakaet; Maryam Kavousi; Bruno H Stricker; M Arfan Ikram; Jan Heeringa; Oscar H Franco; Guy G Brusselle; Lies Lahousse
Journal:  Int J Cardiol       Date:  2018-09-15       Impact factor: 4.164

Review 4.  The Effects of Air Pollution and Temperature on COPD.

Authors:  Nadia N Hansel; Meredith C McCormack; Victor Kim
Journal:  COPD       Date:  2015-12-18       Impact factor: 2.409

5.  Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation.

Authors:  Simon Kochhäuser; Dirk G Dechering; Kathleen Trought; Philip Hache; Tanjah Haig-Carter; Yaariv Khaykin; Zaev Wulffhart; Alfredo Pantano; Bernice Tsang; Lars Eckardt; Atul Verma
Journal:  Can J Cardiol       Date:  2016-02-09       Impact factor: 5.223

6.  Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study.

Authors:  P Buch; J Friberg; H Scharling; P Lange; E Prescott
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

7.  Mitochondrial oxidative stress promotes atrial fibrillation.

Authors:  Wenjun Xie; Gaetano Santulli; Steven R Reiken; Qi Yuan; Brent W Osborne; Bi-Xing Chen; Andrew R Marks
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

8.  Angiogenesis in chronic obstructive pulmonary disease: a translational appraisal.

Authors:  Alessandro Matarese; Gaetano Santulli
Journal:  Transl Med UniSa       Date:  2012-04-30

Review 9.  Atrial fibrillation and microRNAs.

Authors:  Gaetano Santulli; Guido Iaccarino; Nicola De Luca; Bruno Trimarco; Gianluigi Condorelli
Journal:  Front Physiol       Date:  2014-01-24       Impact factor: 4.566
  9 in total
  5 in total

1.  Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease.

Authors:  Rita Pavasini; Gioele Fabbri; Alessio Fiorio; Roberta Campana; Giulia Passarini; Filippo Maria Verardi; Marco Contoli; Gianluca Campo
Journal:  Echocardiography       Date:  2021-05-10       Impact factor: 1.724

Review 2.  Catheter ablation of atrial fibrillation-A key role in heart failure therapy?

Authors:  Beatriz Tose Costa Paiva; Thomas H Fischer; Johannes Brachmann; Sonia Busch
Journal:  Clin Cardiol       Date:  2019-02-12       Impact factor: 2.882

3.  Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis.

Authors:  Fanghui Li; Xiang Tu; Dongze Li; Ying Jiang; Yisong Cheng; Yu Jia; Xinyu Zhang; Hua Fu; Hongde Hu; Jian Jiang; Rui Zeng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation.

Authors:  So-Young Yang; Dong-Won Kang; Jin Hyun Nam; Eue-Keun Choi; Eui-Kyung Lee; Ju-Young Shin; Sun-Hong Kwon
Journal:  Sci Rep       Date:  2022-03-01       Impact factor: 4.996

5.  Factors Associated with Exercise-Induced Desaturation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Chiung-Hsin Chang; Horng-Chyuan Lin; Chia-Hung Yang; Shu-Ting Gan; Chi-Hsien Huang; Fu-Tsai Chung; Han-Chung Hu; Shu-Min Lin; Chih-Hao Chang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.